Rob Hasselman - Elixinol Global Pres Americas
| ELLXF Stock | USD 0.03 0.00 0.00% |
Insider
Rob Hasselman is Pres Americas of Elixinol Global
| Phone | 61 2 4044 4585 |
| Web | https://www.elixinolwellness.com |
Elixinol Global Management Efficiency
The company has return on total asset (ROA) of (0.3266) % which means that it has lost $0.3266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7075) %, meaning that it generated substantial loss on money invested by shareholders. Elixinol Global's management efficiency ratios could be used to measure how well Elixinol Global manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | INSIDER Age | ||
| Steven Lightman | Grown Rogue International | 66 | |
| Yosuke Akita | Eisai Co | 58 | |
| Nadeem Sarwar | Eisai Co | N/A | |
| Obie Strickler | Grown Rogue International | 40 | |
| MD FAAN | Eisai Co | 73 | |
| Adam August | Grown Rogue International | 45 | |
| Ryan Kee | Grown Rogue International | 40 | |
| Teruyuki Masaka | Eisai Co | 45 | |
| Buddy Wilson | Grown Rogue International | N/A | |
Management Performance
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 |
Elixinol Global Leadership Team
Elected by the shareholders, the Elixinol Global's board of directors comprises two types of representatives: Elixinol Global inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elixinol. The board's role is to monitor Elixinol Global's management team and ensure that shareholders' interests are well served. Elixinol Global's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elixinol Global's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kim BradleyWare, Joint Company Secretary | ||
| Glen Zurcher, Account Department | ||
| FCPA BEC, Interim Officer | ||
| Teresa Cleary, G Sec | ||
| Rob Hasselman, Pres Americas | ||
| Josephine Lorenz, Global Controller | ||
| Beata Silber, Global Innovation |
Elixinol Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Elixinol Global a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (1.72) % | |||
| Operating Margin | (1.63) % | |||
| Current Valuation | 2.06 M | |||
| Shares Outstanding | 316.27 M | |||
| Shares Owned By Insiders | 15.67 % | |||
| Shares Owned By Institutions | 4.83 % | |||
| Price To Book | 0.72 X | |||
| Price To Sales | 0.59 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Elixinol Pink Sheet
Elixinol Global financial ratios help investors to determine whether Elixinol Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixinol with respect to the benefits of owning Elixinol Global security.